Q3 2024 Sangamo Therapeutics Inc Earnings Call

Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

Sangamo Therapeutics (SGMO) Tops Q3 Earnings and Revenue Estimates

Sangamo: Q3 Earnings Snapshot

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

individual investors who own 55% along with institutions invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) saw increase in their holdings value last week

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025

Investors in Sangamo Therapeutics (NASDAQ:SGMO) from three years ago are still down 90%, even after 13% gain this past week

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Just Reported And Analysts Have Been Lifting Their Price Targets

Q2 2024 Sangamo Therapeutics Inc Earnings Call